August 19, 2010

Community-based Screening for Hepatocellular Carcinoma in Elderly Residents in a Hepatitis B and C Endemic Area

Yen-Chieh Huang MD 1,2,†, Chih-Fang Huang MD 1,3,†, Kuo-Chin Chang MD 4,5, Shu-Fen Hung RN 4, Jing-Houng Wang MD 4,5, Chao-Hung Hung MD 4,5, Chien-Hung Chen MD, PhD 4,5, Po-Lin Tseng MD 4,5, Kwong-Ming Kee MD 4,5, Yi-Hao Yen MD 4,5, Pei-Shan Tsai RN, MPH 6, Chin-Chen Tsai MD 6, Sheng-Nan Lu MD, MPH, PhD 4,5,*

Journal of Gastroenterology and Hepatology
Accepted Article (Accepted, unedited articles published online for future issues)
DOI: 10.1111/j.1440-1746.2010.06476.x
Journal compilation © 2010 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd

Author Information
1 Departments of Family Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan;
2 Departments of Family Medicine, Antai Tian-Sheng Memorial Hospital, Tongkang, Pingtung, Taiwan;
3 Graduate Institute of Natural Healing Science, College of Science and Technology, Nanhua University, Chiayi, Taiwan;
4 Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan;
5 School of Medicine, Chang Gung University College of Medicine, Taoyuan, Taiwan; and
6 Health Center of Zihguan Township, Kaohsiung, Taiwan.

*Correspondence: Sheng-Nan Lu MD, MPH, PhD,

*Correspondence: Sheng-Nan Lu M.D., M.P.H, Ph.D., Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, 123 Ta Pei Road, Niao Sung 833, Kaohsiung, Taiwan. Tel: +886-7-731-7123 ext. 8301 Fax: +886-7-732-2402 E-mail: juten@ms17.hinet.netc

†* Yen-Chieh Huang, MD and Chih-Fang Huang, MD contributed equally to this study and manuscript

Publication History
Accepted manuscript online: 17 AUG 2010 12:20PM EST
Received date: 08-Jan 2010 Accepted date: 01-Aug-2010

Keywords:
alpha-fetoprotein (AFP);platelet count;community screening;hepatitis C virus (HCV);hepatocellular carcinoma (HCC)

ABSTRACT

Background and Aim: To elucidate a reasonable model and efficacy of hepatocellular carcinoma (HCC) screening on an elderly population.

METHODS: A two-staged HCC screening was conducted in an HCV-endemic area. Firstly, participants underwent blood tests for hepatitis B surface antigen (HBsAg), anti-Hepatitis C (HCV) antibody, serum fetoprotein (AFP), aspartate aminotransferase (AST), alanine aminotransferase (ALT) and platelet count, and subjects who were abnormal for any of the 6 markers were enrolled for 2nd stage ultrasonography. Suspected cases were referred for confirmation. HCC cases were followed for 4 years. All subjects were linked to national mortality and cancer register databases to identify newly developed HCC 30 months after screening.

RESULTS: 461 men and 541 women were screened for HCC, with 15.1% of them testing positive for HBsAg and 44.3% positive for anti-HCV. Among them, 619 (61.8%) met the criteria of ultrasonographic screening; 527 (85.1%) responded, and 16 confirmed HCC (M/F = 8/8, 68.8 ± 8.0 years) cases were detected. All tumor diameters were less than 5cm and 6 of them were less than 2cm. AFP and thrombocytopenia were two independent predictive factors of HCC. Overall survival rates of detected cases were 93.8% and 56.3% in years 1, and 4, respectively. The only good prognostic predictor was “underwent curative treatment”. Besides, another 7 developed HCC and 5 of them were with either thrombocytopenia or AFP elevation.

CONCLUSIONS: Under economical consideration, AFP and platelet count should be feasible screening markers of risk identification. Early detection and prompt treatment resulted in good prognosis of an aged population.

Source

No comments:

Post a Comment